New treatment option for Hand Osteoarthritis
Official title A Prospective Cohort Study of Patients Suffering From Hand Osteoarthritis Symptoms
ClinicalTrials.gov ID: NCT03650673
What this study is testing
- What it's testing
- The late-stage forms of degenerative osteoarthritis (OA) are very debilitating and less affordable to therapy. The main objective is to identify early onset symptoms of hand OA patients through imaging techniques (such as ultrasound and MRI).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60
You may be able to join if
- \- Early digital osteoarthritis must combine the clinical AND radiological definition.
- Clinical definition:
- At least one of the following 4 criteria: Pain or stiffness or swelling or deformity of a digital joint (IPP and / or IPD) A breach of at least one...
- Radiographic definition:
- The presence of the achievement of at least one PPI and / or IPD. Presence of at least two of the following three criteria: pinching, marginal...
You likely can't join if
- \- Consent form signed Exclusion criteria:
- patients suffering from rheumatoid arthritis, rheumatoid psoriasis or any other inflammatory rheumatism
- patients suffering from metabolic diseasis such as gout, hemochromatosis, Wilson's disease; or from congenital disease such as displasie...
- Presence of advanced radiographic osteoarthritis based in Kellgreen Lawrence score (=4) in one joint among the 10 previous sites.
- Not able to provide a sample of blood for any reasons
- MRI contraindication
See the full eligibility criteria
- \- Early digital osteoarthritis must combine the clinical AND radiological definition.
- Clinical definition:
- At least one of the following 4 criteria: Pain or stiffness or swelling or deformity of a digital joint (IPP and / or IPD) A breach of at least one PPI and / or IPD Age under 60 at the time of the first symptoms...
- Radiographic definition:
- The presence of the achievement of at least one PPI and / or IPD. Presence of at least two of the following three criteria: pinching, marginal subchondral condensation, marginal osteophyte Erosion on radiography is not...
- \- Consent form signed Exclusion criteria:
- patients suffering from rheumatoid arthritis, rheumatoid psoriasis or any other inflammatory rheumatism
- patients suffering from metabolic diseasis such as gout, hemochromatosis, Wilson's disease; or from congenital disease such as displasie, osteogenesis,
- Presence of advanced radiographic osteoarthritis based in Kellgreen Lawrence score (=4) in one joint among the 10 previous sites.
- Not able to provide a sample of blood for any reasons
- MRI contraindication
- Being in exclusion period determined by another previous study
- Subject non affiliated to social insurance
- Pregnant or lactating women
- Vulnerable people based in L1121-5 article of CSP
- Elderly subject or protected people disabled to give their consent
- people private of freedom by court or administrative order
The study team makes the final eligibility decision.
Where it's taking place
- Montpellier, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Montpellier, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.